Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens ...
The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...
GlobalData on MSN
FDA approves J&J’s TECNIS PureSee intraocular lens
The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.
The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...
Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for ...
Primary IOL implantation in pediatric open globe injuries with active inflammation showed inferior visual outcomes compared ...
The following Q&A comes from the Centers for Medicare & Medicaid Services website. Q: What codes should hospitals, ambulatory surgery centers and physicians use to report astigmatism-correcting ...
FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results